Skip to main content

Day: January 30, 2025

Nokia Corporation Financial Report for Q4 and full year 2024

Nokia CorporationFinancial Statement Release30 January 2025 at 08:00 EET Nokia Corporation Financial Report for Q4 and full year 2024 Strong Q4 growth and profitability as market trends improveQ4 net sales increased 9% y-o-y in constant currency (10% reported). Network Infrastructure net sales grew strongly with all units contributing, Nokia Technologies grew significantly and Cloud and Network Services also grew in Q4. Comparable gross margin in Q4 increased by 250bps y-o-y to 47.2% (reported increased 280bps to 46.1%), with a strong contribution from Nokia Technologies along with smaller contributions from other businesses. Q4 comparable operating margin increased 380bps y-o-y to 19.1% (reported up 540bps to 15.3%), mainly due to higher gross margin, continued cost control and higher contribution from Nokia Technologies. Q4 comparable...

Continue reading

STMicroelectronics Reports Q4 and FY 2024 Financial Results

PR No: C3309C  STMicroelectronics Reports Q4 and FY 2024 Financial ResultsQ4 net revenues $3.32 billion; gross margin 37.7%; operating margin 11.1%; net income $341 million FY net revenues $13.27 billion; gross margin 39.3%; operating margin 12.6%; net income $1.56 billion Business outlook at mid-point: Q1 net revenues of $2.51 billion and gross margin of 33.8% Start of the company-wide program to resize global cost base*    Geneva, January 30, 2025 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, reported U.S. GAAP financial results for the fourth quarter ended December 31, 2024. This press release also contains non-U.S. GAAP measures (see Appendix for additional information). ST reported fourth quarter net revenues of $3.32 billion, gross...

Continue reading

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds to Beta Bionics from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics, are expected to be $204.0 million. In addition, the underwriters have a 30-day option to purchase up to an additional 1,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions, consisting of 475,000 shares from Beta Bionics and 1,325,000 shares from the selling stockholders named in the prospectus. Beta Bionics will not receive any...

Continue reading

Imperial Provides Update on Mount Polley

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) reports that 2024 metal production from Mount Polley was 35.7 million pounds of copper and 39,108 ounces of gold. The mine met its targets of 34–37 million pounds for copper production and 37-41 thousand ounces for gold production. Red Chris production will be released when the reconciled information is received from Newmont Corporation. Mount Polley Mine – Production During the fourth quarter 1,660,937 tonnes of ore were treated (up 6% compared to Q4 2023). During the quarter 9.242 million pounds copper (up 11% from Q4 2023) and 9,564 ounces gold (down 7.6% from Q4 2023) were produced.Mount Polley Mine Production Three Months Ended December 31   Year Ended December 31    2024 2023   2024 2023  Ore...

Continue reading

UPDATE — Brazilian Rare Earths December 2024 Quarterly Report

Monte Alto depositMonte Alto deposit with high-grade monazite sands overlaying the hard rock REE-Nb-Sc-Ta-U mineralisation – Oblique View to the SouthwestSYDNEY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Brazilian Rare Earths Limited (ASX:BRE / OTCQX: BRELY) (‘BRE’) is pleased to provide its quarterly report for the period ended 31 December 2024. Key highlights during and subsequent to the end of the quarter included: Record Exploration Success Continues at Monte AltoUltra-high-grade rare earth intercepts up to 45.7% TREO, with standout grades of NdPr (69,558 ppm) and DyTb (11,696 ppm) New record assays for niobium (1.7% Nb2O5) and tantalum (962 ppm Ta2O5) with very-high grades of scandium (382 ppm Sc2O3) and uranium (5,781 ppm U3O8) Exploration increased the continuity, depth and scale of the ultra-high-grade REE-Nb-Sc-Ta-U...

Continue reading

Magnera to Report 2025 First Quarter Results on February 6th

CHARLOTTE, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) — Magnera (NYSE: MAGN) expects to release its 2025 first quarter results prior to trading on the New York Stock Exchange on Thursday, February 6, 2025. The earnings release will be available shortly thereafter on Magnera’s website at www.Magnera.com. In conjunction with its release, Magnera’s Executive team will hold a conference call to discuss the 2025 first quarter financial results at 10:00am (ET) on Thursday, February 6, 2025. What: 2025 Q1 Magnera Financial Results, Q&A and Webcast When: Thursday, February 6, 2025Time: 10:00 a.m. ETTelco:  Pre-register (click here to receive dial-in and unique pin for Q&A)Webcast: Listen in option (live and replay) Approximately two hours after the Q&A session, an archived version of the webcast will be available on the Company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.